
Vaccine for new COVID disease in 2025?
Current odds
Live · updates every 20sPrice history
Market stats
Polymarket · CLOBRecent trades
Last 10 fills · live| TIME | SIDE | PRICE | SIZE | VALUE | TRADER |
|---|---|---|---|---|---|
About this market
ContextOn February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013) This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
How trading works
Polymarket uses a central limit order book (CLOB) model — you can buy or sell shares of any outcome at the current market price, or place limit orders at your target price. All positions are settled in USDC when the market resolves.
Resolution
Markets resolve through UMA's Optimistic Oracle. After the market closes, a proposer submits a resolution, followed by a 2-hour dispute window. If no dispute is raised, the resolution is accepted. Disputed markets go to UMA token holder vote.